↑ 薬物リストへ　← 戻る

Protease inhibitors    (DrugBank: -)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
265脂肪萎縮症2

265. 脂肪萎縮症　［臨床試験数：109，薬物数：164（DrugBank：59），標的遺伝子数：26，標的パスウェイ数：94］
Searched query = "Lipodystrophy", "Berardinelli-Seip syndrome", "Lawrence syndrome", "Barraquer-Simons syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 109 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00122655
(ClinicalTrials.gov)		January 200121/7/2005Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With LipoatrophyA Randomized Prospective Study Evaluating the Impact on Fat Distribution of NRTI-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy ANRS 108 NONUKE StudyHIV Infections;HIV Lipodystrophy SyndromeDrug: non-nucleoside reverse transcriptase inhibitors;Drug: nucleoside reverse transcriptase inhibitors;Drug: protease inhibitorsFrench National Agency for Research on AIDS and Viral HepatitisNULLTerminated18 YearsN/ABoth100Phase 4France
2NCT00202241
(ClinicalTrials.gov)		September 199913/9/2005The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDSThe Effects of Anabolic Steroids and Protease Inhibitors on Serum Blood Lipids,Muscle Mass, and Total Body Fat in People Living With HIV/AIDSHIV;AIDS;Lipodystrophy;HyperlipidemiaProcedure: testosterone injectionQueen's UniversityOntario Ministry of Health and Long Term CareCompleted18 YearsN/ABoth30N/ACanada